Abstract
This chapter aims to summarise the general principles of pre conception risk assessment for medical disorders in women presenting for fertility treatment in terms of benefits, scope, purpose and logistics. It discusses the specific risks as a consequence of the medical disorder to the pregnancy and effects of the pregnancy on the medical disorder. It also discusses the modifications that may be needed to the ART procedure in common medical disorders. Finally it explores evidence for effectiveness of pre conception risk assessment in terms of measurable effects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ART Factsheet. European Society of Human Reproduction and Embryology (ESHRE). 2014. http://www.eshre.eu/Guidelines-and-Legal/ART-fact-sheet.aspx.
Long term trends in fertility treatment. Human Fertilisation and Embryology Authority (HFEA). 2011. http://www.hfea.gov.uk/2585.html.
Obesity facts and figures World Health Organisation Fact sheet N°311. European Association for the Study of Obesity (EASO). http://easo.org/obesity-facts-figures.
RCOG release: Alcohol in pregnancy: information for you. The Royal College of Obstetricians and Gynecologists; 2015.
Diabetes in pregnancy. NICE clinical guideline No. 63. Issued March 2008, modified December 2014. http://www.nice.org.uk/guidance/cg63.
Sheffield JS, Butler-Koster EL, Casey BM, McIntire DD, Leveno KJ. Maternal diabetes mellitus and infant malformations. Obstet Gynecol. 2002;100(5 Pt 1):925–30.
Starikov R, Bohrer J, Goh W, Kuwahara M, Chien EK, Lopes V, Coustan D. Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus. Pediatr Cardiol. 2013;34(7):1716–22.
Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–5.
Cignini P, Cafà EV, Giorlandino C, Capriglione S, Spata A, Dugo N. Thyroid physiology and common diseases in pregnancy: review of literature. J Prenat Med. 2012;6:64–71.
Pre-conception: advice and management. In Clinical Knowledge summaries. National Institute for Health and Care Excellence. Last revised 2015. http://cks.nice.org.uk/pre-conception-advice-and-management.
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081–125.
Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE clinical guideline CG 107. 2010.
Cardiac disease and pregnancy. Good practice No 13. Royal College of Obstetricians and Gynaecologists. June 2011.
Lawley CM, Algert CS, Ford JB, Nippita TA, Figtree GA, Roberts CL. Heart valve prostheses in pregnancy: outcomes for women and their infants. J Am Heart Assoc. 2014;3(3), e000953.
Cleuziou J, Hörer J, Kaemmerer H, Teodorowicz A, Kasnar-Samprec J, Schreiber C, Lange R. Pregnancy does not accelerate biological valve degeneration. Int J Cardiol. 2010;145(3):418–21.
Basude S, Hein C, Curtis SL, Clark A, Trinder J. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study. BJOG. 2012;119(8):1008–13.
Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol. 2011;68(10):1275–81.
Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, Tudur Smith C, Marson AG. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014;10, CD010236.
Costedoat-Chalumeau N, Amoura Z, Villain E, Cohen L, Piette JC. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther. 2005;7(2):69–73.
Jacobsen AE, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital based case control study. J Thromb Haemost. 2008;6:905–12.
Reducing the risk of thrombosis and embolism during pregnancy and puerperium. Green top guideline N. 37a. RCOG, Nov 2009.
Schaefer C, Peters P, Miller RK, editors. Drugs during pregnancy and lactation: treatment options and risk assessment. 2nd ed. Oxford: Academic; 2007.
The management of ovarian hyperstimulation syndrome Green top guideline No. 5. RCOG Sept 2006.
Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010;10:63.
De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010;10, CD007950.
Winterbottom JB, Smyth RM, Jacoby A, Baker GA. Preconception counselling for women with epilepsy to reduce adverse pregnancy outcome. Cochrane Database Syst Rev. 2008;3, CD006645.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bhide, P., Bhide, A. (2017). Pre-conception Risk Assessment: Medical Problems. In: Jayaprakasan, K., Kean, L. (eds) Clinical Management of Pregnancies following ART. Springer, Cham. https://doi.org/10.1007/978-3-319-42858-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-42858-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42856-7
Online ISBN: 978-3-319-42858-1
eBook Packages: MedicineMedicine (R0)